Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
NR507 / NR 507: Advanced Pathophysiology Final Exam Study Guide 2022/2023 ) | Chamberlain College Of Nursing.
Typology: Study Guides, Projects, Research
1 / 33
Chapter 35: Structure and Function of the Pulmonary System
Tara Morgan
The primary function of the pulmonary system is the exchange of gases between
the environmental air and the blood.
○ Ventilation, the movement of air into and out of the lungs
Diffusion, the movement of gases between air spaces in the lungs and the
bloodstream
Perfusion, the movement of blood into and out of the capillary beds of the
lungs to body organs and tissues
The first two functions (ventilation and diffusion) are carried out by the
pulmonary system and the third (perfusion) by the cardiovascular system.
Normally the pulmonary system functions efficiently under a variety of conditions
and with little energy expenditure.
Structures of the Pulmonary System
The pulmonary system includes two lungs and the upper and lower airways, and
the blood vessels that serve them; the chest wall, or thoracic cage; and the
diaphragm.
○ 3 in the right lung (upper, middle, lower)
○ 2 in the left lung (upper, lower)
The mediastinum is the space between the lungs and contains the heart, great
vessels, and esophagus.
The diaphragm is a dome-shaped muscle that separates the thoracic and
abdominal cavities and is involved in ventilation.
FIGURE 35.1 Structural Plan of the Respiratory System. The inset shows alveolar
sacs where the interchange of oxygen and carbon dioxide takes place through the
walls of the grapelike alveoli. Capillaries surround the alveoli.
The lungs are protected from a variety of exogenous contaminants by a series of
mechanical and cellular defenses.
These defense mechanisms are so effective that in the healthy individual,
contamination of the lung tissue itself, particularly by infectious agents, is rare.
Upper
respiratory tract
mucosa
Maintains constant temperature and humidification of gas entering
the lungs; traps and removes foreign particles, some bacteria, and
noxious gases from inspired air
Nasal hairs and
turbinates
Trap and remove foreign particles, some bacteria, and noxious
gases from inspired air
turbinates gases from inspired air
Branching
airways
Disrupt laminar flow and enhance deposition of particles and
pathogens on ciliated mucosa
Mucous blanket Protects trachea and bronchi from injury; traps most foreign
particles and bacteria that reach the lower airways
Innate immune
proteins
Lysozyme, lactoferrin, defensins, collectins (surfactant protein A
[SP-A] and surfactant protein D [SP-D]), and immunoglobulin A
(IgA); recognize and promote killing of pathogens
Cilia Propel mucous blanket and entrapped particles toward the
oropharynx, where they can be swallowed or expectorated
Alveolar
macrophages
Ingest and remove bacteria and other foreign material from alveoli
by phagocytosis (see Chapter 7)
Surfactant Enhances phagocytosis of pathogens and allergens in alveoli;
down-regulates inflammatory responses
Irritant receptors
in nares
(nostrils)
Stimulation by chemical or mechanical irritants triggers sneeze
reflex, which results in rapid removal of irritants from nasal
passages
Irritant receptors
in trachea and
large airways
Stimulation by chemical or mechanical irritants triggers cough
reflex, which results in removal of irritants from the trachea and
large airways
Conducting Airways
The conducting airways provide a passage for the movement of air into and out of the
gas-exchange structures of the lung.
Lined with ciliated mucosa with a rich vascular supply that warms and humidifies
inspired air and removes foreign particles from it as it passes into the lungs.
The mouth and oropharynx provide for ventilation when the nose is obstructed or
when increased flow is required, for example, during exercise. Filtering and
humidifying are not as efficient with mouth breathing.
FIGURE 35.2 Structures of the Upper Airway.
The larynx connects the upper and lower airways and consists of the endolarynx and
its surrounding triangular-shaped bony and cartilaginous structures.
The slit-shaped space between the true cords forms the
The endolarynx is formed by two pairs of folds: the false vocal cords (supraglottis)
and the true vocal cords.
The laryngeal box is formed by three large cartilages
Epiglottis
Thyroid
▪ Arytenoid
▪ Corniculate
▪ Cuneiform
○ And three smaller cartilages-connected by ligaments
The supporting cartilages prevent collapse of the larynx during inspiration and
swallowing.
The internal laryngeal muscles control vocal cord length and tension, and the external
laryngeal muscles move the larynx as a whole.
The internal muscles contract during swallowing to prevent aspiration into the trachea
and contribute to voice pitch.
The trachea , which is supported by U-shaped cartilage, connects the larynx to the
bronchi , the conducting airways of the lungs.
This area is very sensitive and when stimulated can cause coughing and airway
narrowing.
Aspirated fluids or foreign particles thus tend to enter the right lung rather than
the left.
The left mainstem bronchus branches from the trachea at about a 45 - degree angle.
The right mainstem bronchus is slightly larger and more vertical than the left
(branches at about a 20- to 30-degree angle from the trachea).
The right and left main bronchi enter the lungs at the hila, or “roots” of the lungs,
along with the pulmonary blood and lymphatic vessels.
From the hila the main bronchi branch into lobar bronchi and then to segmental and
subsegmental bronchi, and finally end at the sixteenth division in the smallest of the
conducting airways, the terminal bronchioles
FIGURE 35.3 Conducting Airways and Respiratory Unit. A, Structures of respiratory
airways. B, Changes in bronchial wall with progressive branching. C, Electron
micrograph of alveoli: long white arrow identifies type II alveolar cells (pneumocytes -
secretes surfactant); short white arrowhead identifies pores of Kohn; red arrow
identifies alveolar capillary. D, Plastic cast of pulmonary capillaries at high
magnification.
In the large bronchi (up to approximately the tenth division), the connective tissue
layer contains cartilage.
The epithelial lining of the bronchi contains single - celled exocrine glands—the mucus-
secreting goblet cells —and ciliated cells.
High columnar pseudostratified epithelium lines the larger airways and becomes
progressively thinner, changing to columnar cuboidal epithelium in the bronchioles
and squamous epithelium in the alveoli
The submucosal glands of the bronchial lining produce a mucous blanket that
protects the bronchial epithelium.
The ciliated epithelial cells rhythmically beat this mucous blanket toward the trachea
and pharynx, where it can be swallowed or expectorated by coughing.
and pharynx, where it can be swallowed or expectorated by coughing.
Toward the terminal bronchioles, ciliated cells and goblet cells become more sparse,
and smooth muscle and connective tissue layers thin
Gas-Exchange Airways
These thin-walled structures participate in gas exchange, and the clusters of
alveoli are sometimes called the acinus
The conducting airways terminate in the respiratory (terminal) bronchioles, alveolar
ducts, and alveoli
The walls of the respiratory bronchioles are very thin, consisting of an epithelial
layer devoid of cilia and goblet cells, very little smooth muscle fiber, and a very
thin and elastic connective tissue layer.
These bronchioles end in alveolar ducts , which lead to alveolar sacs made up
of numerous alveoli.
The bronchioles from the sixteenth through the twenty-third divisions contain
increasing numbers of alveoli and are called respiratory bronchioles.
The alveoli
are the primary gas-exchange units of the lung, where oxygen enters the
blood and CO2 is removed
Tiny passages called pores of Kohn permit some air to pass through the septa from
alveolus to alveolus, promoting collateral ventilation and even distribution of air
among the alveoli. The lungs contain approximately 50 million alveoli at birth and
about 480 million by adulthood.
FIGURE 35.4 Alveoli. Bronchioles subdivide to form tiny tubes called alveolar ducts that end in
clusters of alveoli called alveolar sacs.
The alveolar septa consist of an epithelial layer and a thin, elastic basement
membrane but no muscle layer
Type II alveolar cells secrete surfactant , a lipoprotein that coats the inner
surface of the alveolus and facilitates its expansion during inspiration, which
lowers alveolar surface tension at end-expiration, thereby preventing lung
collapse (atelectasis).
Contribute to control of lung inflammation by decreasing release of
proinflammatory mediators
Bacteriostatic and function as opsonins in presenting pathogens to alveolar
macrophages.
Macrophages are the most numerous immune cells present in the lung environment
and provide innate immune defense of the airway from the bronchi to the alveoli.
In the alveoli, alveolar macrophages provide protection by clearing surfactant from the
lung and ingesting foreign material and pathogens that reach the alveolus, preparing
these substances for removal through the lymphatics - Phagocytosis
Surfactant and alveolar macrophages work together with the normal pulmonary
microbiota to prevent lower lung infection.
Pulmonary and Bronchial Circulation
serves as a filtering system that removes clots, air, and other debris from the
circulation
circulation
FIGURE 35.5 The Pulmonary Circulation. The right and left pulmonary veins and
arteries and the branching capillaries are illustrated. Note the pulmonary artery
carries venous blood, and the pulmonary vein carries arterial blood.
Although the entire cardiac output from the right ventricle goes into the lungs, the
pulmonary circulation has a lower pressure and resistance than the systemic
circulation.
Pulmonary arteries are exposed to about one-fifth the pressure of the systemic
circulation and have a much thinner muscle layer.
About one-third of the pulmonary vessels are filled with blood (perfused) at any given
time.
More vessels become perfused when right ventricular cardiac output increases.
Therefore, increased delivery of blood to the lungs does not normally increase mean
pulmonary artery pressure.
During exercise, pulmonary arterial pressure will normally increase, but not to more
than 30 mmHg and is age and sex dependent.
The pulmonary artery
divides and enters the lung at the hilus, branching with each
main bronchus, and with the bronchi at every division.
The arterioles divide at the terminal bronchiole to form a network of pulmonary
capillaries around the acinus.
Capillary walls consist of an endothelial layer and a thin basement membrane, which
often fuses with the basement membrane of the alveolar septum
The shared alveolar and capillary walls compose the alveolocapillary membrane , a
very thin membrane made up of the;
These extremely thin alveolar walls are easily damaged and can leak plasma and
blood into the alveolar space.
With normal perfusion, approximately 100 mL of blood in the pulmonary capillary bed
is spread very thinly over about 70 to 100 m2 of alveolar surface area.
FIGURE 35.6 Cross Section Through an Alveolus Showing Histology of the Alveolar -
Capillary Membrane (Respiratory Membrane). The dense network of capillaries forms
an almost continuous sheet of blood in the alveolar walls, providing a very efficient
arrangement for gas exchange.
Unlike the pulmonary arteries, which follow the branching bronchi, pulmonary veins
are dispersed randomly throughout the lungs and then leave the lung at the hila and
enter the left atrium.
The bronchial circulation is part of the systemic circulation and receives 1% of the
cardiac output.
and lymph nodes in the thorax.
Not all of the capillaries drain into their own venous system. Some empty into the
pulmonary vein and contribute to the normal venous admixture of oxygenated and
deoxygenated blood or right-to-left shunt
The bronchial circulation does not participate in gas exchange.
Fluid and alveolar macrophages migrate from the alveoli to the terminal
bronchioles, where they enter the lymphatic system.
The superficial lymphatic capillaries drain the membrane that surrounds the
lungs.
Both deep and superficial lymphatic vessels leave the lung at the hilum through
a series of mediastinal lymph nodes.
The lymphatic system plays an important role in keeping the lung free of fluid
and providing immune defense.
Lung vasculature also includes deep and superficial pulmonary lymphatic
capillaries.
Control of the Pulmonary Circulation
The caliber of pulmonary artery lumina decreases as smooth muscle in the arterial
walls contracts.
Contraction (vasoconstriction) and relaxation (vasodilation) primarily occur in
response to local humoral conditions, even though the pulmonary circulation is
innervated by the autonomic nervous system (ANS), as is the systemic circulation.
The most important cause of pulmonary artery constriction is a low alveolar partial
pressure of oxygen (PAO2).
If only one segment of the lung is involved, the arterioles to that segment
constrict, shunting blood to other, well-ventilated portions of the lung. This reflex
improves the lung's efficiency by better matching ventilation and perfusion.
If all segments of the lung are affected, vasoconstriction occurs throughout the
pulmonary vasculature, and pulmonary hypertension (elevated pulmonary artery
pressure) can result.
Vasoconstriction caused by alveolar and pulmonary venous hypoxia, often termed
hypoxic pulmonary vasoconstriction , results from an increase in intracellular
calcium levels in vascular smooth muscle cells in response to low oxygen
concentration and the presence of charged oxygen molecules called oxygen free
radicals.
Chronic alveolar hypoxia can result in inflammation and structural remodeling in
pulmonary arterioles, causing permanent pulmonary artery hypertension that
eventually leads to right heart failure.
An elevated PaCO2 value without a drop in pH does not cause pulmonary artery
constriction.
Other biochemical factors that affect the caliber of vessels in pulmonary circulation
are:
Chest Wall and Pleura
The intercostal muscles of the chest wall, in conjunction with the diaphragm , perform
the muscular work of breathing.
The t horacic cavity
is contained by the chest wall and encases the lungs
The membrane covering the lungs is the visceral pleura; that lining the thoracic
cavity is the parietal pleura.
Normally only a thin layer of fluid secreted by the pleura (pleural fluid) fills the
pleural space. About 18 mL of fluid is in the pleural space with a pH of about 7.6,
a few cells, about 1 g/dL protein, and glucose and electrolyte concentrations that
approximate those of the plasma.
This lubricates the pleural surfaces, allowing the two layers to slide over each
other without separating. Pressure in the pleural space is usually negative or
subatmospheric (−4 to −10 mmHg).
FIGURE 35.7 Thoracic (Chest) Cavity and Related Structures. The thoracic cavity is
divided into three subdivisions (left and right pleural divisions and mediastinum) by a
partition formed by a serous membrane called the pleura.
Chapter 35
Functions of the pulmonary system
Keisha Svitak
Functions of the Pulmonary System:
**1. Ventilate the alveoli
Ventilation ≠ Respiration
Ventilation- mechanical movement of gas or air into and out of lungs
Respiration- the exchange of O2 and CO2 during cellular metabolism
Ventilatory rate- breaths/min
Tidal volume- volume of air per breath (L/breath)
ventilatory rate/tidal volume = L/min of effective ventilation
Minute volume (Minute ventilation) - volume of air inspired & expired per minute
calculated by
pH- concentration of hydrogen ions (H+)
Observation of ventilatory rate (breaths/min), pattern, effect -- No
By arterial blood gas analysis measurement of PaCO2 --YES
How does the healthcare professional accurately determine adequacy of
ventilation?
CO2 elimination is necessary to maintain normal levels (important role in
regulation of acid-base balance)
CO2 in arterial blood diffuses across blood-brain barrier until PaCO2 is
equal on both sides (blood & CSF)
Regulates ventilation through effect on H+ content in CSF
↑ PaCO2 leads to ↓ pH ( ↑H+)
PaCO2- partial pressure of arterial CO2, normal PaCO2 = 40mm Hg
PaO2- partial pressure of arterial O2, normal PaO2 = 60mm Hg (measured by
arterial blood gas)
↓PaO2 & pH (well below normal) leads to ↑ ventilation
- As PaO2 ↑, O2 moves from plasma into RBC (erythrocytes) and binds to
hemoglobin molecules and continues to bind until hemoglobin molecules are
all binded to oxygen. Oxygen continues to diffuse across alveolocapillary
membrane until PaO2 and PAO2 equilibriate which ceases O2 diffusion.
- PaO2 values <60 reflects steep part of oxyhemoglobin dissociation curve (Fig
35.16) due to decreased hemoglobin affinity for oxygen
- PaO2 values >60 reflects flatter curve on oxyhemoglobin dissociation curve
- PaO2 values >60 reflects flatter curve on oxyhemoglobin dissociation curve
due to maximum saturation of hemoglobin with oxygen in lungs
PAO2- partial pressure of alveolar O2, normal PAO2 = 104mmHg at sea level
with relaxed breathing
Therefore a pressure gradient of about 60mmHg facilitates diffusion of oxygen
from the alveolus into the capillary (Fig 35.15)
- Different values for PAO2 can be calculated if there are changes in the inspired
oxygen content or the PaCO2, which are common occurrences in clinical
settings.
Chemoreceptors- monitor pH, PaCO2, & PaO2 levels
CSF = 1-2mmHg PaCO
a. Sensitive to very small changes in pH of
i. Depth & rate of ventilation which leads to
PaCO2 of arterial blood gas < PaCO2 CSF from CO2 diffusing out
CSF leads to
ii.
iii. Return to normal pH level
b. Central chemoreceptors respond to PaCO2 leads to pH ( H+) by:
Which results in prolonged PaCO2 bicarbonate retention
from renal compensation
2. Bicarbonate diffuses in CSF to normalize pH
Except not under long-term conditions such as COPD as receptors
become insensitive to small changes in PaCO2 from hypoventilation
i.
Peripheral Chemoreceptors take over when central chemoreceptors
reset by chronic hypoventilation
ii.
Central chemoreceptors often able to maintain a normal PaCO2 level under
many conditions including strenuous activity
c.
Central Chemoreceptors- monitor arterial blood indirectly by sensing pH
changes in CSF
As PaO2 & pH peripheral chemoreceptors in carotid bodies respond
by ventilation
i.
ii. Additive effect ventilation if PaCO2 in addition to PaO2 & pH
a. Primarily sensitive to O2 levels in arterial blood (PaO2)
b. Somewhat sensitive to PaCO
Peripheral Chemoreceptors-kick in primarily when central chemoreceptors
reset by chronic hypoventilation
Lung is innervated by ANS and has 3 types of lung sensory receptors:
Cough reflex from noxious aerosols (vapors), gases, and particulate
matter (inhaled dust)
a.
Also stimulated by inflammatory mediators (histamine, serotonin,
prostaglandins), by drugs
b.
Located primarily in epithelium of proximal larger airways (nearly absent in
distal airway)
c.
Irritant receptors- cause bronchoconstriction & ventilatory rate
This reflex assists with ventilation and may protect against excess lung
inflation
a.
This reflex active in newborns & only in adults with high tidal volumes
(exercise, mechanical ventilation)
b.
Located in smooth muscles of airways & sensitive to increases in size or
volume of the lungs
c.
Stretch receptors- cause ventilatory rate & volume leads to Hering-Breuer
expiratory reflex
Located near capillaries in the alveolar septa and in other airway locations
as nociceptors
a.
b. Sensitive to increased pulmonary capillary pressure
Pulmonary C-fiber receptors- cause rapid, shallow breathing; laryngeal
constriction on expiration and mucous secretion; hypotension; and
bradycardia; may be associated with dyspnea
ANS- control diameter of airway lumen by stimulating bronchial smooth muscle
to contract (parasympathetic receptors) and relax (sympathetic receptors).
Figure 35.
Neurochemical Control of Ventilation (Fig 35.9)-
occurs in neurons located in brainstem:
inspiratory nerve cells (located in medulla) that
transmit impulses out to diaphragm & intercostal
muscles
impulses from various receptors & various stimuli
which alter breathing patterns to restore normal
blood gases
a. Receives impulses from:
i. PNS receptors in carotid & aortic bodies
ii. Receptors in the lung
iii. Various stimuli (mechanical, neural,
chemical)
Alterations in any of following mechanics of breathing will increase the work of
breathing to achieve adequate ventilation & oxygenation of the blood:
i. primary muscle of ventilation
Flattens with contraction, volume thoracic cavity & negative
pressure draws gas in lungs
ii.
a. Diaphragm
i. Anterior portion of ribs is elevated with contraction
ii. volume of thoracic cavity by AP diameter
b. External intercostal muscles (muscles between the ribs)
4. Major muscles of inspiration (Fig 35.10)
Also enlarge the thorax (but not as efficiently as diaphragm) by its AP
diameter
a.
b. Include the sternocleidomastoid muscle & scalene muscles
Utilized when minute volume is very high (strenuous exercise or from
disease affecting elastic recoil such as emphysema) or disease blocks the
conducting airways
c.
**5. Accessory Muscles of Inspiration (Fig 35.10):
Intraabdominal pressure with contraction, pushing diaphragm up &
volume of thorax
i.
a. Includes the abdominal muscles
i. Pulls down the anterior ribs, AP diameter of thorax
b. Includes the intercostal muscles
Utilized when minute volume is high, when coughing, when airway
obstructed
c.
7. Accessory muscles of expiration (Fig 35.10):
As alveolus becomes smaller, more pressure is required to inflate it,
making it harder to breathe, especially if water lines the alveoli
i.
1. As alveolus becomes smaller, the surface tension
Alveoli larger & less numerous in apexes (upper portions) of
the lungs
a.
2. As alveolus becomes larger, the surface tension
If surfactant production is disrupted/suboptimal, the surface
tension causing alveolar collapse, lung expansion, work of
breathing, and severe gas-exchange abnormalities
Alveolar surface tension can be decreased by surfactant (a lipoprotein
produced by alveoli, allows alveolar ventilation and keeps alveoli free
of fluid)
ii.
Alveolar surface tension- tendency liquid molecules to adhere together
when exposed to air
a.
Elastin fibers in the alveolar walls and in surrounding small airways &
pulmonary capillaries
i.
ii. Surface tension at alveolar air-liquid interface
b. Elasticity lungs (recoils by collapse inward around hila) caused by:
Opposing forces of recoil in lungs and chest wall create small
negative intrapleural pressure
i.
During inspiration: diaphragm & intercostal muscles contract, air
flows into lungs with most tidal volume distributed to bases of
lung (where compliance is greater), and chest wall expands
During expiration: the muscles relax and elastic inward recoil of
lungs causes thorax to decrease in volume until balance between
chest wall & lung recoil forces
Balance between recoil in lungs and chest occurs at rest at end of
expiration (Fig 35.11)
ii.
Elasticity of chest wall (recoils by expanding outward laterally) is
supported by configuration of its bones and musculature
c.
Measured by volume change (tidal volume)/pressure change (airway
or pleural pressure)
i.
Compliance- reciprocal of elasticity, measure of lung and chest wall
distensibility (stretch)
d.
8. Elastic properties of the lungs & chest wall
or pleural pressure)
1. Occurs with normal aging and disorders such as emphysema
compliance indicates lungs or chest wall is abnormally easy to
inflate and has lost some elastic recoil
ii.
1. Occurs with ARDS, pneumonia, pulmonary edema, & fibrosis
Work of breathing may be increased considerably when lung
(pulmonary edema) & chest wall compliance (spinal deformity
or obesity) leading to increased O2 consumption & inability to
maintain adequate ventilation
compliance indicates lungs or chest wall is abnormally stiff or
difficult to inflate
iii.
Normally very low airway resistance (especially in conducting airways
of lungs due to large cross-sectional area)
i.
1/2 to 2/3 resistance occurring primarily in the nose, followed by
oropharynx & larynx
ii.
Airway resistance- determined by length, radius, diameter, & cross-
sectional area of the airways
a.
b. Bronchodilation- airway resistance
Bronchoconstriction- airway resistance from irritants, inflammatory
mediators
c.
i. Edema of the bronchial mucosa
Airway obstructions such as mucus plugging (asthma or bronchitis),
tumors, or foreign bodies
ii.
Other means of airway resistance
d.
9. Resistance to airflow through the conducting airways
Gas transport involves delivery of O2 to the cells of the body (#1) and removal
of CO2 (#2) (gas exchange is compromised if respiratory or cardiovascular
disorder impairs any step in this process)
Ventilation of the lungs, diffusion of oxygen from alveoli into capillary blood,
perfusion of systemic capillaries with oxygenated blood, & diffusion of oxygen
from systematic capillaries into cells
Diffusion of CO2 from the cells into the systematic capillaries, perfusion of the
pulmonary capillary bed by venous blood, diffusion of CO2 into alveoli, removal
of CO2 from the lung by ventilation
Blood remains in pulmonary capillary bed for about 3/4 second, but only 1/
second required for oxygen concentration to equalize across the
alveolocapillary membrane. This allows for ample time for oxygen to diffuse
into the blood even during increased cardiac output, which speeds blood flow.
Barometric pressure (PB) (atmospheric pressure)- pressure exerted by gas
molecules in air at specific altitudes
A. Sea level (barometric pressure is 760mm Hg)
a. Calculated by % gas x barometric pressure
i. Greater in smaller area due to more collisions of gas molecules
ii. with heat as heat speed of gas molecules which collisions
b. Measurement of gas pressure
That is why pulmonary function laboratories specify temp & humidity
of a gas at time of all pressure & volume measurements.
Partial pressure of water vapor exerts pressure 47mm Hg at 98.6F
regardless of barometric pressure. However, before determining partial
pressures of other gases in the mixture, water vapor must be subtracted
from barometric pressure [ie. (760-47) x % gas].
c.
B. Partial pressure-portion of total pressure exerted by any individual gas
Amount of oxygen in alveoli (PAO2) estimated by using alveolar gas
equation:
i.
Partial pressure of oxygen molecules (PO2) is much greater in alveolar gas
than in capillary blood which promotes rapid diffusion from alveolus into the
capillary
a.
equation:
PAO2 = PiO2 (inspired partial pressure of O2) - PaCO2/0.8 (the respiratory
quotient)
ii.
PiO2 = Barometric pressure (760) - vapor pressure (47mmHg) x FiO
[fraction (%) of inspired air (0.21)]
iii.
b. Figure 35.15 shows partial pressure of respiratory gases in normal respiration
- Ventilation & perfusion are greatest in the lower lobes as most tidal volume
occurs in alveoli lung bases and because greater pressure causes greater
perfusion.
Ventilation-Perfusion Ratio or V/Q: ratio of ventilation to perfusion
A. Ventilation exceeds perfusion in apexes
B. Perfusion exceeds ventilation in bases
Normal V/Q ratio is 0.8 (which is amount perfusion exceeds ventilation under
normal condition)
Ventilation & perfusion
1. Standing or sitting: Pulmonary blood flow greatest to bases of lungs
Right Side-lying: Pulmonary blood flow greatest on lateral side right lung
& medial side left lung
Left Side-lying: Pulmonary blood flow greatest on lateral side left lung &
medial side right lung
4. Supine: Pulmonary blood flow greatest on posterior side of both lungs
depend on body position with areas of lungs most gravity dependent become
the best ventilated and perfused (Fig 35.13)
Blood flow through pulmonary capillary bed increases in regular
increments from apex to base
Distribution of perfusion also affected by alveolar pressure (gas pressure in
alveoli) in lungs (Fig 35.14).
i. No blood flow occurs due to capillary bed collapsing
ii. Located at apex of lung
1. Zone I: Alveolar pressure (PA) > arterial (Pa) & venous pressures (Pv)
Blood flow occurs, but alveolar pressure compresses the venules (venous
ends of capillaries)
i.
ii. Located above level of left atrium
2. Zone II: arterial pressure (Pa) > Alveolar pressure (PA) > venous pressure (Pv)
Blood flow fluctuates, depending on difference between arterial & venous
pressures
i.
ii. Located at base of lung
3. Zone III: Both arterial (Pa) & venous pressures (Pv) > Alveolar pressure (PA)
Oxygen Transport
- Approximately 1000ml (1L) of O2 is transported to the cells of the body each
minute by:
3% oxygen dissolves in plasma (0.003ml/dL per mmHg) (as diffuses across
alveolocapillary membrane) where it exerts pressure of oxygen in arterial blood
(PaO2).
5. 97% oxygen binds to hemoglobin molecules (max 1.34ml/g)
SaO2- % of available hemoglobin that is bound to oxygen (measured using
oximeter)
Figure 35.
Figure 35.
Figure 35.
oximeter)
Total arterial oxygen content- hemoglobin (Hb) available to bind to oxygen,
SaO2, & PaO
Total venous oxygen content- normal venous oxygen content is 15-16ml/dL, the
partial pressure of mixed venous blood (PvO2) & venous oxygen saturation
(SvO2) are used in place of SaO2 & PaO2 above
Often seen as compensatory mechanism in pulmonary diseases that
impair gas exchange
Those with cardiovascular disease compensatory mechanism to
accelerate cardiac output is ineffective, therefore requires compensatory
mechanism of increasing Hb more important
in hemoglobin concentration may O2 content
in hemoglobin concentration below normal value of 15mL/DL of blood O
content
Oxyhemoglobin Association and Dissociation (Fig 35.16)
Oxyhemoglobin (HbO2)- forms when hemoglobin molecules bind with oxygen
in the lungs
Hemoglobin saturation with oxygen-where oxygen binds to hemoglobin
Hemoglobin desaturation- where oxygen is released from hemoglobin (now
able to carry more CO2 than hemoglobin saturated with O2)
Oxyhemoglobin dissociation curve- graph plots hemoglobin saturation &
desaturation results in S-shaped curve
which promotes association in the lungs & inhibits dissociation in the
tissues
**2. Lower partial pressure is necessary to maintain 50% O2 saturation
*In Lungs caused by CO2 diffusing from blood into alveoli which reduces
CO2 level
A. Left shift- indicates hemoglobin's increased affinity for oxygen
Increase in ease in which oxyhemoglobin dissociates & oxygen moves
into cells
**2. Larger partial pressure is necessary to maintain 50% O2 saturation
Caused by hyperthermia & increased levels of 2,3-DPG (substance in
erythrocytes)
*In tissues caused by increased levels of CO2 & H+ produced by metabolic
activity
B. Right shift- indicates hemoglobin's decreased affinity for oxygen
*Bohr effect-The shift in oxyhemoglobin dissociation curve caused by changes
in CO2 & H+ concentration in the blood
Carbon Dioxide Transport:
- CO2 is 20x more soluble than O2 and diffuses quickly from tissue cells into
blood & enhanced when O2 diffuses out of blood and into cells
- Approximately 200mL of CO2 is produced by the tissues per minute at rest as
byproduct of cellular metabolism transported in blood by:
Dissolved in plasma as CO2 diffuses out of cells into the blood (5% arterial,
10% venous)
- CO2 combines with H20 with the help of the enzyme carbonic anhydrase,
which forms carbonic acid that quickly dissociates into H+ and
bicarbonate (HCO3-)
Transported as bicarbonate (HCO3-) out of RBC into the plasma (60% arterial,
90% venous)
- Drop in SaO2 at tissue level increases ability of Hb to carry CO2 back to
lung by attaching to reduced hemoglobin (desaturated hemoglobin)
Combined with blood proteins (hemoglobin in particular) to form carbamino
compounds (Fig 3.13)
Haldane effect (effect of O2 on CO2 transport)- In tissue capillaries, O
dissociation from hemoglobin facilitates the pickup of CO2 & binding of O2 to
hemoglobin in the lungs facilitates the release of CO2 from the blood.
- Diffusion of CO2 in the lung is so efficient that diffusion defects that cause
hypoxemia (low O2 content in blood) do not cause hypercapnia (excessive CO
in blood).
Chapter 36
- Clinical manifestations of pulmonary alterations-Carlo Enrico Yap
I. Signs and Symptoms of Pulmonary Disease
A. Dyspnea
Most common symptom of cardiac and respiratory dse
daily activities
Mechanism:
stimulation of mechanoreceptors and chemoreceptors that interact
with the respiratory centers and motor cortex
OR adults who are thin)
Dyspnea on exertion:
dyspnea that presents during exercise
night gasping
for air and must sit up or stand to relieve the dyspnea
B. Cough
stimulate the receptors in the airway → vagus nerve stimulation
stimulating cough reflex
o Ex: Upper resp tract infections, acute bronchitis, PNA, CHF, PE, or aspiration
Acute cough:
resolves in 2-3 weeks OR resolves w/ treatment of underlying dse
o Non-smokers chronic cough = post nasal drainage, nonasthmatic eosinophilic
bronchitis, asthma, GERD, heightened cough reflex sensitivity
o Smokers chronic cough = chronic bronchitis
o A inhibitors → chronic cou resolved when d
C. Abnormal Sputum
o Not to be confused with hemoptysis: vomiting blood → dark, acidic pH + food
Infarction
o Indicates: damage to bronchi d/t infection/inflammation, cancer, pulmonary
D. Abnormal Breathing Patterns
change in rate, depth, regularity, and effort of breathing
o Caused by metabolic acidosis i.e. strenuous exercise
and no expiratory pause
o Obstruction of LARGE airways→ slowed rate but increased effort, long
inspiration and expiration, stridor (high-pitched during inspiration), and wheezing
(whistling sounds on expiration).
o Obstruction of SMALL airways→ rapid ventilation, small tidal volume,
increased effort, prolonged expiration
Pulmonary fibrosis→ small tidal volume, rapid rate
o i.e. shock and severe cerebral hypoxia
- Gasping : irregular and quick inspiration with expiratory pause
o Apnea Æ high-volume ventilations Æ Apnea
o Results from conditions that lead to slow blood flow to the brain stem Æ
slowed impulses that send info to brain stem
Cheyne-Stokes respirations:
alternating periods of deep and shallow.
E. Hypo/Hyperventilation
- Hypoventilation: inadequate alveolar ventilation →increased PaCO2 (hypercapnia)
o Can cause somnolence or disorientation; secondary hypoxemia (high CO
displaces O2 in the alveolus).
increased pH in the blood →
respiratory acidosis
o Common is severe anxiety and acute head injury
- Hyperventilation:
lungs expel CO2 at a higher rate → decreased PaCO
(hypocapnia)→respiratory alkalosis
F. Cyanosis: bluish discoloration of the skin and mucus membranes
Raynaud's dse, cold environments, severe stress
o Caused by pulmonary dses and cardiac right-to-left shunts
membranes and lips
and carbon monoxide poisoning
G. Clubbing: bulbous enlargement of the end of a digit
lung abcess,CHF
H. Pain : usually originates in the pleurae, airways, or chest wall.
infection/inflammation of parietal pleura i.e. pleuritis, pleurisy, PE
pain (angina pectoris)
reproduced by pressing on the sternum or ribs
II. Conditions Caused by Pulmonary Disease or Injury
A. Hypercapnia: hypoventilation→ increased PaCO2 → cerebral vasodilation →
increased ICP → coma, somnolence
o Drugs Æ central depression
o Dses of the medullar e.g. CNS infections, trauma
o Abnormalities in spinal conduction pathways
o Neuromuscular disease e.g myasthenia gravis
o Abnormalities of the thoracic cage
o Obstruction of large airways, tumors, sleep apnea
o problems in O2 delivery in the alveoli
o problems in diffusion and perfusion
B. Hypoxemia:
low PaO
Decrease in inspired
oxygen (decreased FiO2)
High altitude
Low oxygen content of gas mixture
Enclosed breathing spaces (suffocation)
Hypoventilation of the
alveoli
Lack of neurologic stimulation of the respiratory center
(oversedation, drug overdose, neurologic damage)
Defects in chest wall mechanics (neuromuscular
disease, trauma, chest deformity, air trapping)
Large airway obstruction (laryngospasm, foreign body
aspiration, neoplasm)
Increased work of breathing (emphysema, severe
asthma)
Ventilation-perfusion
mismatch
Asthma
Chronic bronchitis
Pneumonia
Acute respiratory distress syndrome
Atelectasis
Pulmonary embolism
Alveolocapillary diffusion
abnormality
Edema
Fibrosis
Emphysema
Decreased pulmonary
capillary perfusion
Intracardiac defects
Intrapulmonary arteriovenous malformations
C. Acute Respiratory Failure: aka respiratory lung failure
pH </= 7.
edema, or PE).
Chapter 36:Disorders of the Chest Wall and Pleura
Samantha Garey
Pleural Abnormalities
Clinical manifestations: sudden pleural pain, tachypnea, and dyspnea. Absent or
decreased breath sounds. Tension pneumo: hypoxemia, tracheal deviation away
from affected lung, and hypotension.
Diagnosis: Chest XR, ultrasound, CT scan
Treatment: Aspiration, usually with insertion of chest tube that is attached to a
water seal drainage system with suction
Pneumothorax: the presence of air or gas in the pleural space cause by a rupture in the
visceral pleura (which surround the lungs) or the parietal pleura and chest wall.
➢
pleura. Ruptured blebs damage visceral pleura creating a conduit for air to
travel from the lower airways into the pleural space (bronchopleural
fistulae)
syndrome
surgical procedure that tears pleura
Primary and secondary can present as either open or tension:
Open pneumothorax: air pressure in the pleural space equals barometric pressure because
air that is drawn into the pleural space during inspiration is forced back out during expiration.
air that is drawn into the pleural space during inspiration is forced back out during expiration.
Tension pneumothorax: the site of pleural rupture act as a one-way valve, permitting air to
enter on inspiration but preventing its escape by closing on expiration. As more air enters the
pleural space, air pressure begins to exceed barometric pressure pushing against the recoiled
lung causing compression atelectasis, displacing the heart, great vessels, and trachea.
Tension Pneumothorax. Air in the pleural space causes the lung to collapse around the hilum and may shift the trachea and mediastinal contents
(heart and great vessels) toward the other lung.
Transudate
(Hydrothor
ax)
Watery fluid that diffuses out of capillaries
beneath the pleurae (i.e., capillaries in lung or
chest wall)
Cardiovascular disease-causing hypertension:
liver or kidney disease that disrupts plasma
protein production, causing hypoproteinemia
(decreased oncotic pressure in the blood
vessels)
Exudate
Fluid rich proteins (leukocytes, plasma
proteins of all kinds) that migrate out of
capillaries
Infection, inflammation, or malignancy of the
pleurae that stimulates mast cells to release
biochemical mediators that increase capillary
permeability
Empyema
(pus)
Detritus of infection (microorganisms,
leukocytes, cellular debris) dumped into the
pleural space by blocked lymphatic vessels
Pulmonary infections, such as pneumonia; lung
abscesses; infected wounds
Microorganisms- staphylococcus aureus, E. coli,
anaerobic bacteria, and Klebsiella pneumoniae
Hemothor
ax (blood)
Hemorrhage into the pleural space Traumatic injury, surgery, rupture, or
malignancy that damage blood vessels
Chylothora
x (chyle)
Chyle (milky fluid containing lymph and fat
droplets) that is dumped by lymph vessels
into the pleural space instead of passing from
the gastrointestinal tract to the thoracic duct
Traumatic injury, infection, or disorder that
disrupts lymphatic transport
Larger effusions can cause dyspnea, compression atelectasis and impaired ventilation causing
hypoxemia.
Physical exam: decreased breath sounds, pleural friction rub upon auscultation, dullness to
percussion on the affected side.
➢ Infected Empyema effusion: cyanosis, fever, tachycardia, cough, pleural pain
Diagnosis & treatment: Chest imaging and thoracentesis (needle aspiration), sputum culture,
chest tube placement, surgical interventions, antibiotics.
Chapter 36: Pulmonary disorders- Brenda Milner
Restrictive lung disorders are characterized by a decrease in compliance of
lung tissue. This causes more effort to expand the lungs during inspiration.
People with lung restriction have dyspnea, increased resp rate and decreased
tidal volume.
Restrictive lung diseases can cause V/Q mismatch and affect the
alveolocapillary membrane, this can reduce diffusion of O2 from alveoli into the
blood and cause hypoxemia.
Common restrictive disorders:
3 types:
1) Compression atelectasis- external pressure on lung tissue (tumor or
fluid)
2) Absorption atelectasis- gradual absorption of air from obstructed or
hypoventilated alveoli or inhaling concentrated O2.
3) Surfactant impairment- decreased production of surfactant
Aspiration – fluid or solids get passed into the lungs.
Bronchiectasis- persistent abnormal dilation of bronchi.
BOOP is a complication in which the alveoli and bronchioles are filled with
plugs of connective tissue.
BOS is an inflammatory fibrotic process that is a complication of lung
transplant.
Bronchiolitis- most common in children. Inflammation of small airways or
bronchioles.
Idiopathic pulmonary fibrosis- more common in men after age 60. Most
common idiopathic lung disorder, survival rate 2-5 years. Chronic
inflammation at multiple lung sites. Alveolar collapse and fibroproliferative
response cause increased thickening of the alveolocapillary membrane
causing decreased diffusion of O2 and hypoxemia.
Pulmonary Fibrosis- large amount of fibrous or connective tissue in the lungs
(scar tissue).
Environmental lung disorders:
Exposure to toxic gases- Common toxic gases are ammonia, hydrogen
chloride, sulfur dioxide, chlorine, phosgene, and nitrogen dioxide. Inhaled
particles can cause damage to airway epithelium, cilia, and alveoli. Oxygen
toxicity occurs with high concentrations of supplemental oxygen.
Pneumoconiosis- inhalation of inorganic dust particles. The dust of silica,
asbestos and coal are most common cause.
Hypersensitivity pneumonitis- inhalation of organic particles or fumes. Is an
allergic inflammatory disease.
Systemic disorders
Granulomatosis disorders: Sarcoidosis, Wegener granulomatosis,
lymphomatoid granulomatosis, eosinophilic granuloma.
Connective tissue diseases: RA, lupus, scleroderma, polymyositis, Sjogren
syndrome, cystic fibrosis, Goodpasture syndrome.
Pulmonary edema- excess water in the lung. Most common cause left-sided
heart disease. Pulmonary edema begins to develop at the pulmonary capillary
wedge pressure or left atrial pressure of 20mmHg.
Factors for pulmonary edema left-sided heart disease, causing increased
pulmonary venous pressure; injury to pulmonary capillary endothelium (ARDS)
and inhalation of toxic gases; lymphatic obstruction.
Postobstructive pulmonary edema is a rare life-threatening complication that
can occur after relief of upper airway obstruction.
High-altitude pulmonary edema occur at altitudes usually more than 8000- 10000
feet.
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS)- acute lung
inflammation and diffuse alveolocapillary injury.
ARDS most severe. Acute onset of bilateral infiltrates on xray not explained by
cardiac failure. A low ratio of partial pressure of arterial oxygen to the fraction
of inhaled oxygen. Most common factors genetic, sepsis, trauma.
Exudative (inflammatory)- 72 hours release of inflammatory cytokines.
Lungs become less compliant and work of breathing increases, ventilation
of alveoli decreases, and hypercapnia develops.
Proliferative- within 1-3 weeks after injury resolution of pulmonary edema
and proliferation of fibroblasts, myofibroblasts and type II pneumocytes
with surfactant recover.
Fibrotic- 2 - 3 weeks after injury remodeling and fibrosis occur.
ARDS 3 phases:
Clinical manifestation of ARDS:
Evaluation and treatment:
History of lung injury, examination (Fine inspiratory crackles), ABG’s and chest x - ray.
Treatment include early detection, supportive care, prevention of complications.
Obstructive Pulmonary Disease- airway obstruction that is worse with expiration.
Infiltration of the lung by inflammatory cells with the release of large number of
cytokines that cause airway damage and mucus production. Most common are
asthma and COPD.
Asthma- chronic inflammation of the bronchial mucosa that cause bronchial
hyperresponsiveness, constriction of the airway, and variable airflow obstruction that
is reversible. Can develop at any age. Asthma phenotypes are observable
characteristics that include eosinophilic asthma (allergic) vs. neutrophilic asthma,
exercise-induced asthma, aspirin-sensitive asthma, age-at-onset asthma, or steroid
nonresponsive asthma. Endotypes are subgroups that describe the underlying
pathophysiology to the phenotypes.
Early asthmatic response- acute bronchoconstriction that reaches a maximum in the
first 30 minutes and resolves within 1-3 hours. Antigen exposure to the bronchial
mucosa activates dendritic cells to present the antigen to T helper cells, which
differentiate into Th2 cells releasing cytokines. These activate inflammatory cells and
cytokines causing vasoconstriction, increased capillary permeability, mucosal edema,
bronchial smooth muscle constriction and increased mucus secretion.
Late asthmatic response- 4 - 8 hours after early response. Bronchospasm, edema and
mucus secretion with obstruction to airflow. Impaired expiration causes air trapping,
hyperinflation distal to obstructions and increased work breathing. With progressive
obstruction of expiratory airflow, air trapping is severe and lungs and thorax become
hyperexpanded, respiratory muscles are mechanically disadvantaged leading to
decrease in tidal volume with increasing CO2 retention and respiratory acidosis,
which signals respiratory failure.
which signals respiratory failure.
Management of asthma include avoiding allergens or irritants, control symptoms,
preventing exacerbation.
COPD- a common, preventable disease characterized by airflow limitation that is not
fully reversible and is progressive.
2 primary phenotypes:
Chronic bronchitis- hypersecretion of mucus and chronic cough for 3-12 months for
at least 2 years. Inspired irritants promote bronchial inflammation, causing bronchial
edema.
Emphysema- permanent enlargement of gas exchange airways accompanied by
destruction of alveolar walls. Can be centriacinar: septal destruction occurs in the
respiratory bronchiolar walls and alveolar ducts in the center of the pulmonary lobule
(upper lobes) occurs in smokers, paraseptal; similar to centricinar but occurs adjacent
to the pleura and septa of the pulmonary lobule, panacinar; involves the alveolar and
respiratory bronchiolar walls, resulting in global air space expansion with damage
randomly distributed and involving the lower lobes.
rd
leading cause of death in the US.
Risk factors for COPD smoking, occupational dusts and chemicals, indoor air
pollution, and outdoor air pollution
Respiratory Tract Infections-
cold, sore throat, laryngitis (upper airway)
Acute bronchitis- inflammation of large airways or bronchi 90% caused by viruses
Pneumonia- infection of the lower respiratory tract caused by bacteria, viruses, fungi,
protozoa or parasites. 8
th
leading cause of death in US.
Community-acquired (CAP)- m ost common reason for hospitalization.
Healthcare-associated (HCAP)-
occurring in people with recent hospital stays,
nursing homes or other healthcare facility.
Ventilator-associated (VAP)- intubated patients
Pneumococcal Pneumonia- acute lung infection 4 inflammatory phases:
consolidation, red hepatization, gray hepatization, and resolution.
Viral Pneumonia- lung infection caused by the flu. Seasonal, usually mild
TB- lung infection caused by M. tuberculosis. The pathogen can survive in
macrophages, resist lysosomal killing, multiply in the cell and transmit into a stage of
dormancy making it resistant to host defense and medication treatment. Leading
cause of death from a curable disease throughout the world. Highly contagious,
transmitted person to person by inhalation of airborne droplets.
Pulmonary vascular disease
PE- thrombus blocks a portion of the pulmonary vascular, a tissue fragment, or an air
bubble. Depending on location and size can cause hypoxic vasoconstriction,
pulmonary edema, pulmonary hypertension, or death. Usually come from a DVT in
the lower leg.
Pulmonary artery hypertension- caused by elevated left ventricular pressure,
increased blood flow through the pulmonary system, obstruction of vascular bed,
active constriction caused by hypoxemia or acidosis. Mean pulmonary pressure
greater than 25mmHg at rest.
Cor Pulmonale- caused by pulmonary hypertension which causes right ventricular
enlargement. If pulmonary hypertension is not treated will cause right ventricular
failure.
Malignancies of the respiratory tract
Laryngeal cancer- Squamous cell carcinoma of the vocal cords. Occurs most often
in men. Causes hoarseness.
Lung cancer-
Most frequent cancer deaths in the US. Most common cause from
smoking.
Cancer cell types include non–small cell lung cancer (squamous cell carcinoma,
adenocarcinoma, large cell undifferentiated carcinoma) and neuroendocrine tumors
(small cell carcinoma and bronchial carcinoid tumors). Other tumors include small cell
(oat cell) carcinoma, bronchial adenoma, adenocystic tumors (cylindromas),
mucoepidermoid carcinomas (bronchial tumors), and mesothelioma. Each type arises
in a characteristic site or type of tissue, causes distinctive clinical manifestations, and
differs in likelihood of metastasis and prognosis.
Chapter 37
- Structure and function- Mittal Patel
Week 2: Chapter 37 Children Upper Respiratory Disorders-Britt Ware-Ojo
Upper Airway Obstruction (UAO)
Stridor is a harsh, vibratory sound of the variable pitch caused by turbulent flow
through the partially obstructed airway.
o
Infections
is 2 or more episodes of croup without respiratory tract infection (RTI) ▪
▪ Starts and resolves quickly mostly in older children
▪ Recurrent Croup (spasmodic croup):
▪ Occurs in children 6 months to 5 yrs old, peak incidence is about at 2yrs old
▪ Acute laryngotracheitis (croup):
▪ Subglottic edema from infection
The mucous membrane of the larynx is tight on the cartilage, whereas
those of the subglottic space are loose which causes mucosal and
submucosal edema.
▪
The cricoid cartilage is structurally the narrowest point of the airway,
making edema is this area critical.
▪
With edema it causes increased work of breathing which generates more
negative intrathoracic pressure which can cause collapse of the upper
airway.
▪
▪ Pathophysiology of croup
Rhinorrhea (runny nose) ▪
▪ Sore throat
▪ Low grade fever
▪ Harsh (seal-like) cough
Hoarse voice ▪
▪ Inspiratory stridor
▪ Clinical Manifestations:
A barking cough and viral symptoms require no treatment ▪
▪ Having stridor, retractions, or agitation is a sign it’s a sicker child.
▪ The Westley Croup Score is a tool that scores:
▪ Croup is mild, moderate, or severe
Nebulized epinephrine stimulates a- and b- adrenergic receptors
which decrease airway secretions and mucosal edema
o
▪ Glucocorticoids are oral or injected which improves symptoms in 6 hours
Caused by Haemophilus influenzas type B (Hib) ▪
There is an immunization for Hib, so cases are rare but 25% of epiglottis is still
caused by Hib. Due to no immunizations.
▪
▪ Infants less than 1 year old are at greater risk.
Non infectious causes include trauma from foreign body inhalation and chemical
burns.
▪
Epiglottis is from the posterior tongue base and covers the laryngeal inlet during
swallowing. It has a rich blood and lymphatic circulation.
o
Bacteria of the mucous and inflammation can cause edema, obstructing the
upper airway
o
▪ Usually occurs in children 2-6 years old
High Fever ▪
▪ Irritability
▪ Sore throat
▪ Hot potato voice
Inspiratory stridor ▪
▪ Respiratory distress
Children will usually be leaning toward (tripod position), drooling and difficult
swallowing
▪
Examination of the throat can cause laryngospasm and cause respiratory
collapse. Death can occur shortly after.
▪
PNA, cervical lymph nodes inflammation, otitis, and rarely meningitis or septic
arthritis may occur.
▪
▪ Don’t exam the throat
▪ Intubation sometimes
▪ Culture of the throat, antibiotics
Corticosteroids ▪
If caused by Hib, rifampin should be administered to the household once daily
for 4 days.
▪
Occurs sometimes due to group A beta-hemolytic Streptococci (GABHS) and
methicillin-resistant Staphylococcus aureus (MRSA)
▪
▪ It’s swelling of the tonsils and pharynx and may cover the mucosa.
▪ Can also occur from infectious mononucleosis (mono)
Treatment includes antibiotics and corticosteroids ▪
o Fever
Sore throat o
o Difficulty swallowing
o Trismus
o Pooling of saliva
o Muffled voice
▪ Peritonsillar abscess
▪ Recurrent tonsillitis may require adenotonsillectomy.
▪ Most common, life threatening upper airway infection for children
▪ MRSA, Hib, GABHS, or Moraxella catarrhalis
▪ Fungus can be the cause in immunocompromised children
▪ Recurring infection
Caused by ▪
Airway edema and copious purulent secretions lead to airway obstruction ▪
Obstruction can be worse due to mucosal sloughing and tracheal
pseudomembrane.
▪
PNA, cardiac arrest, acute respiratory distress syndrome (ARDS), multiple
organ dysfunction.
▪
▪ Death can occur due to:
Tachypnea ▪
▪ Fever
▪ Stridor
▪ Hoarse voice
Cough ▪
▪ Increased secretions from mouth and nose
▪ Clinical presentation
▪ Antibiotics
Inbutation ▪
▪ Treatment
▪ Aerobic, anaerobic, or polymicrobial infection
o Caused by
Occurs around 4 years old from other nasopharyngeal infection or penetrating
local injury.
o
Retropharyngeal Abscesses:
local injury.
o
▪ Fever
Neck pain ▪
▪ Drooling
▪ Stridor
▪ Dysphagia
Respiratory distress ▪
o Symptoms include:
Antibiotics ▪
▪ Incision and drain (I&D)
o Treatment:
Aspiration of Foreign Bodies
o Nuts,
o Seeds
o Hard candy
o Small pieces of hot dog
Toys o
o Coins
o Beans
o Batteries and magnets
o Coughing, choking, wheezing, or gagging.
Cough, stridor, hoarseness, inability to speak, decreased breath sounds,
respiratory distress, agitation or panic.
o
o Sweeping the oral airway or the abdominal thrust
o Bronchoscopic removal
Antibiotics if the a small object is lodged for a long period of time and the child
has atelectasis, PNA, lung abscess, or blood-tinged sputum.
o
Angioedema
Is localized edema involving the deep subcutaneous layers of the skin or mucous
membranes
o By allergy to peanuts, cow’s milk, chicken eggs
Increased levels of bradykinin mediate this adverse effect by causing vasodilation,
increased vascular permeability, and histamine release.
o Epi, antihistamines, and corticosteroids
o This is a rare but serious medical problem
o 50% of the cases happen in childhood, ages 8-19.
Angioedema occurs to the limbs, genitalia, abdominal and pelvic area as well as
the face
o
o Labs diagnose C-1 INH
o Treatment
An inherited deficiency of the plasma protein C-1 inhibitor (C-1 INH) causes
hereditary angioneurotic edema (HAE).
Congenital Malformations
o Choanal atresia
o Laryngeal atresia
Tracheal stenosis o
Obstructive Sleep Apnea Syndrome (OSAS):
Is partial or intermittent complete UAO during sleeping with disruption of normal
ventilation and sleep patterns.
o Second hand smoke
Snoring o
o Genetics
o Socioeconomic status
Possible influences:
o OSAS involves the CNS, cardiovascular, metabolic, and immune systems
Airway narrowing and increased upper airway collapsibility are common causes
of OSAS
o
Obstruction during sleep causes increase respiratory effort, oxygen
desaturation, hypercapnia and arousal.
o
▪ Adenotonsillar hypertrophy,
▪ Obesity
Craniofacial anomalies ▪
o Airway narrowing can be caused by
o Infants have a greater risk for OSAS because of their anatomy.
o Cerebral palsy and Down syndrome reduced motor tone of the upper airway.